首页> 外文会议>Emerging Interfaces of Physical Sciences and Technology >Chemical modification of Ciprofloxacin IV formulation to combat solubility and stability issues
【24h】

Chemical modification of Ciprofloxacin IV formulation to combat solubility and stability issues

机译:环丙沙星IV配方对抗溶解度和稳定性问题的化学改性

获取原文

摘要

Parenteral are sterile dosage form of therapeutic agent that are free of viable micro- organisms and they are injected through the skin or mucous membranes into the internal body compartments. Ciprofloxacin is a classic drug (Model drug) which is used in treating different kinds of severe bacterial infections. It is weakly basic and shows solubility only in acidic medium but it leads to irritation when injected. This problem can be solved by adding chemical modifiers like PEG-400 and PG at low concentration which would give 100% bioavailability with no toxicity and stable in pH 7.4. This study is performed to enhance solubility of Ciprofloxacin IV infusion by adding PEG-400 and PG have 75.33±0.57 and 98.66±0.52 mg/mL respectively. All formulations (F1-F9) were found to be sterile, clear, isotonic with blood plasma. Stability study showed that all formulations remains stable at temperature 40±2°C and 75±5% RH. Among all formulations F3 is best suited and passed all evaluation parameters.
机译:肠胃外是治疗剂的无菌剂型,其不含活的微生物,并且它们通过皮肤或粘膜注入内部体隔室。环丙沙星是一种经典药物(模型药物),用于治疗不同种类的严重细菌感染。它是弱碱性的并且仅在酸性培养基中显示溶解性,但在注射时导致刺激。通过在低浓度下添加PEG-400和PG等化学改性剂可以通过添加毒性100%的生物利用度并在pH 7.4中稳定来解决该问题。该研究进行了通过添加PEG-400和PG分别通过添加PEG-400和PG增强环丙沙星IV输注的溶解度。发现所有制剂(F1-F9)都被发现是无菌的,透明,等渗,血浆。稳定性研究表明,所有制剂在40±2°C和75±5%RH温度下保持稳定。在所有制剂中,F3最适合并通过所有评估参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号